Vimarsana
Biggest News Aggregation in the World

Page 22 - Accelerate Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accelerate Diagnostics Today - Breaking & Trending Today

Accelerate Diagnostics (NASDAQ:AXDX) vs. Cue Health (NASDAQ:HLTH) Head-To-Head Contrast - Vimarsana News

Accelerate Diagnostics (NASDAQ:AXDX) vs. Cue Health (NASDAQ:HLTH) Head-To-Head Contrast

Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Insider and Institutional Ownership 65.5% of Accelerate Diagnostics shares […]

360Dx Top 30 Inches Up in May After April Plummet - Vimarsana News

360Dx Top 30 Inches Up in May After April Plummet

Of the 30 diagnostic companies in the index, 13 saw their share prices increase, while 17 saw stock prices decline.

Source: 360dx.com
Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022 - Vimarsana News

Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief Executive Officer, Jack Phillips, will present at the 42nd Annual...

Accelerate Diagnostics: Q1 Earnings Snapshot - Vimarsana News

Accelerate Diagnostics: Q1 Earnings Snapshot

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Monday reported a loss of...

Source: ctpost.com
Accelerate Diagnostics Registers Microbial ID Sample Prep, Blood Culture Kit With FDA - Vimarsana News

Accelerate Diagnostics Registers Microbial ID Sample Prep, Blood Culture Kit With FDA

The firm said the new workflow eliminates the need to batch multiple specimen tests, cutting hours off the wait for microbial ID results for positive blood cultures.

Source: 360dx.com